OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review of Different Vaccines and Strategies to Combat COVID-19
S. Sabitha, Nagarajan Shobana, Pandurangan Prakash, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 737-737
Open Access | Times Cited: 17

Showing 17 citing articles:

Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target
Jiandong Shi, Tingfu Du, Junbin Wang, et al.
Science Advances (2023) Vol. 9, Iss. 22
Open Access | Times Cited: 27

Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis
Kuan Rong Chan, Clara WT Koh, Dorothy Hui Lin Ng, et al.
EBioMedicine (2023) Vol. 89, pp. 104472-104472
Open Access | Times Cited: 15

Stroke Following Coronavirus Disease 2019 Vaccination: Evidence Based on Different Designs of Real-World Studies
Junyu Liu, Fang Cao, Chun Luo, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 10, pp. 1336-1346
Open Access | Times Cited: 8

Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon
Dalal Nour, Mohamad Bachar Ismail, Marwan Osman, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0302579-e0302579
Open Access | Times Cited: 2

Recent Advances in ROS-Scavenging Metallic Nanozymes for Anti-Inflammatory Diseases: A Review
Adityanarayan Mohapatra, In‐Kyu Park
Chonnam Medical Journal (2023) Vol. 59, Iss. 1, pp. 13-13
Open Access | Times Cited: 7

An overview of protein-based SARS-CoV-2 vaccines
Yogesh R. Suryawanshi
Vaccine (2023) Vol. 41, Iss. 42, pp. 6174-6193
Closed Access | Times Cited: 6

The COVID-19 Pandemic Is Over, but the Virus Still Lingers
Ludovico Abenavoli
Diseases (2024) Vol. 12, Iss. 3, pp. 57-57
Open Access | Times Cited: 1

LEVERAGING THE SUCCESS OF MRNA LIPID NANOPARTICLE VACCINE IN COVID-19 TREATMENT: A NARRATIVE REVIEW ON ITS POTENTIAL APPLICATION IN MALARIA TREATMENT
Franklyn Nonso Iheagwam, Eniola Deborah Adedoyin
International Journal of Applied Pharmaceutics (2024), pp. 59-66
Open Access | Times Cited: 1

Severe rhabdomyolysis secondary to COVID-19 mRNA vaccine in a teenager
Aidan Pucchio, Maya Heled Akiva, Helena Evangeliou, et al.
Pediatric Nephrology (2022) Vol. 38, Iss. 6, pp. 1979-1983
Open Access | Times Cited: 6

Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, Japan
Takahiro Sanada, Tomoko Honda, Masahiko Higa, et al.
Journal of Infection and Chemotherapy (2022) Vol. 29, Iss. 3, pp. 339-346
Open Access | Times Cited: 4

Molecular basis of Ad5-nCoV Vaccine-Induced Immunogenicity
Dongyang Dong, Yutong Song, Shipo Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Recombinant Expression and Purification of Novel COVID-19 Vaccine Candidate in Escherichia coli BL21 (DE3)
Alok Kumar Singh, Navneet Kumar Verma, Prevesh Kumar, et al.
Biosciences Biotechnology Research Asia (2024) Vol. 21, Iss. 2, pp. 689-703
Open Access

Pharma Companies’ Generosity and Doctors’ Attendance
Harish Gupta, Ajay Kumar Patwa
Journal of Medical Evidence (2024) Vol. 5, Iss. 3, pp. 266-267
Open Access

The Coping Strategies and Facilities Needed to Manage the COVID-19 Pandemic: A Systematic Review
Bentolhoda Asgari, Mohammad Taghi Rezvan, Esmaeil Mazroui Nasrabadi
Disaster Prevention and Management Knowledge (2023) Vol. 13, Iss. 3, pp. 278-295
Open Access

Page 1

Scroll to top